Navigation Links
GE Healthcare Selects PS320 Fetal Simulator for Corometrics monitor fleet
Date:7/9/2012

EVERETT, Wash., July 9, 2012 /PRNewswire/ -- Fluke Biomedical announced today GE Healthcare has selected the PS320 Fetal Simulator to help maintain their fleet of Corometrics 250, 250cx and 170 series patient monitors.  The pocket-sized PS320 simulates both fetal and maternal ECG as well as uterine activity to ensure proper function of fetal monitors.

(Photo: http://photos.prnewswire.com/prnh/20120709/SF36296)

(Logo: http://photos.prnewswire.com/prnh/20120130/SF43337LOGO-b)

The PS320 Fetal Simulator signals a variety of physiological parameters, patterns and conditions and is unique in its ability to simulate twins. An optional mechanical heart creates fetal heart sounds for testing fetal monitor ultrasound cables and transducers.   Ideal for preventive maintenance testing, troubleshooting and repairs, the PS320 is also a favorite for simulating a wide range of clinical scenarios for training labor-and-delivery staff in how to recognize normal and abnormal responses between mother, fetus and monitor.

"We're delighted to hear GE Healthcare has selected the PS320 Fetal Simulator to test their fleet of Corometrics fetal monitors," noted Christopher Rayburn, Director of Marketing for Fluke Biomedical.  "Our companies are both known for best-in-class equipment and time-tested dedication to patient safety."

For more information on the PS320 Fetal Simulator, visit www.flukebiomedical.com/PS320.

About Fluke Biomedical Fluke Biomedical is the premiere, global provider of test and measurement equipment and services to the healthcare industry.  We strive to be the best at delivering innovative solutions to improve quality of global health.  We serve biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals and are continually expanding our range of solutions to a broader range of health and safety professionals.  For more information on Fluke Biomedical, visit www.flukebiomedical.com.  

For More Information Mandy Allen Marketing Communications Manager (425) 446-5494 mandy.allen@flukebiomedical.com


'/>"/>
SOURCE Fluke Biomedical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
2. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
3. Solta Medical to Present at the JMP Securities Healthcare Conference
4. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
5. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
6. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
7. Uroplasty To Present At The JMP Securities Healthcare Conference
8. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
9. PatientPay from Zepherella Now Offers Real-time Pricing, Automatic Payment Reconciliation for Healthcare Providers and Patients
10. ViroPharma To Participate In The JMP Securities Healthcare Conference
11. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec 5, 2016 Research ... Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease ... - Global Forecasts to 2021" report to their offering. ... , , ... USD 730.7 Million in 2021 from USD 574.8 Million in 2016, ...
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ Cartilage ... Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - Forecast ... USD 779.8 Million by 2021 from USD 414.6 Million in 2016, ... 2016 to 2021. Continue Reading ... ...
(Date:12/5/2016)... India , December 5, 2016 According to a ... Type and by Application - Global Opportunity Analysis and Industry Forecast, 2014 - ... is expected to reach $5,255 million by 2022, growing at a CAGR of ... with more than four-fifths share. Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... Novato, CA (PRWEB) , ... December 05, 2016 ... ... company, has extended its partnership with leading global lifestyle design firm kathy ireland® ... , Worldwise® and kathy ireland® Worldwide entered into an exclusive licensing agreement three ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive Laboratories™ is one of ... to enhance production of nitric oxide (NO). , NitroGenesis Pro™ is made with ... twice as effectively and sustains NO blood levels twice as long as comparable ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... BSI and ... the United States and Canada for distribution of their natural fruits and beverage ... line is an exciting addition to our Life Sciences product portfolio,” said Steve ...
Breaking Medicine News(10 mins):